Dermatology Drugs Market Size, Share & COVID-19 Impact Analysis, By Application (Acne, Psoriasis, Atopic Dermatitis, and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2023-2030

ATTRIBUTE

DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 8.2% from 2023-2030

Unit

Value (USD Billion)

Segmentation

By Application

• Acne
• Atopic Dermatitis
• Psoriasis
• Others

By Route of Administration

• Oral
• Parenteral
• Topical

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America (By Application, Route of Administration, Distribution Channel, and Country)
• U.S. (By Application)
• Canada (By Application)
• Europe (By Application, Route of Administration, Distribution Channel, and Country/Sub-Region)
• U.K. (By Application)
• Germany (By Application)
• France (By Application)
• Italy (By Application)
• Spain (By Application)
• Scandinavia (By Application)
• Rest of Europe (By Application)
• Asia Pacific (By Application, Route of Administration, Distribution Channel, and Country/Sub-Region)
• China (By Application)
• Japan (By Application)
• India (By Application)
• Australia (By Application)
• Southeast Asia (By Application)
• Rest of Asia Pacific (By Application)
• Latin America (By Application, Route of Administration, Distribution Channel, and Country/Sub-Region)
• Brazil (By Application)
• Mexico (By Application)
• Rest of Latin America (By Application)
• Middle East & Africa (By Application, Route of Administration, Distribution Channel, and Country/Sub-Region)
• GCC (By Application)
• South Africa (By Application)
• Rest of the Middle East & Africa (By Application)